The Justice Department announced today that Jeffrey McIndoo, of Phoenix, and his company, JeffMac Investments LLC doing business as SARMS Pharm LLC (SARMS Pharm), has pleaded guilty to an information in connection with the illicit sale of potentially dangerous chemical substances known as “SARMs” – selective androgen receptor modulators that mimic the effects of anabolic steroids when ingested into the body. SARMs are not approved by the U.S. Food & Drug Administration (FDA).
“The Justice Department and its partners will continue to actively pursue companies and individuals who sell smuggled and potentially harmful substances to American consumers,” said Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division. “Smuggled SARMs have no place in the national marketplace, and we will endeavor to keep these substances out of the reach of consumers.”
McIndoo, the owner/operator of SARMS Pharm, admitted to introducing an unapproved drug into interstate commerce, while SARMS Pharm pleaded guilty to a conspiracy to smuggle SARMs from China into the United States. In total, between 2017 and 2022, SARMS Pharm earned gross profits totaling at least $3.5 million from selling SARMs. As part of its plea, SARMS Pharm agreed to forfeit $1.8 million the sum of the proceeds retained by the company.
The defendants pleaded guilty before U.S. Magistrate Judge Boyle for the District of Arizona. McIndoo faces a maximum penalty of one year in prison. As part of the plea agreements, JeffMac Investments LLC will shutter its business and will no longer smuggle or sell SARMS.
This case was investigated by FDA’s Office of Criminal Investigations.
This case was prosecuted by Senior Litigation Counsel David Sullivan and Assistant Director Patrick Runkle of the Civil Division’s Enforcement & Affirmative Litigation Branch.
